Santa Cruz Biotechnology offers a broad range of KIR2DS4 monoclonal antibodies for immunology and cell biology research. KIR2DS4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIR2DS4, a member of the killer immunoglobulin-like receptor (KIR) family, plays a crucial role in the regulation of natural killer (NK) cell activity and immune response. The receptor actively participates in recognizing and responding to infected or transformed cells, making it significant in cancer immunology and infectious disease research. Understanding KIR2DS4 function provides valuable insights into immune evasion mechanisms and potential therapeutic targets. Researchers can explore NK cell activation pathways and cellular interactions using specific detection methods. Advanced visualization techniques enable detailed examination of KIR2DS4 expression patterns and localization within cellular compartments. Comprehensive analysis of KIR2DS4 helps reveal its role in immune system regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of immune system dynamics and developing innovative therapeutic strategies.